Lonza Delivers Solid 2024 Performance with CER Sales in Line with Prior Year and 29.0% CORE EBITDA Margin
In 2024, Lonza delivered sales of CHF 6.6 billion in line with prior year (-0.2% CER1) CORE EBITDA of CHF 1.9 billion at…
Newsrooms
SXG Confirms Third High-Grade Gold-Antimony Mineralised Zone at Sunday Creek Project
Mawson Gold Limited (“Mawson” or the “Company”) (TSXV:MAW) (Frankfurt:MXR) (PINKSHEETS: MWSNF) - https://www.commodity-…
Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche
The Vacaville site is one of the largest biologics manufacturing facilities in the world Acquisition extends Lonza’s US…
Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel)
Lonza to manufacture CASGEVY®, the world’s first CRISPR/Cas9 gene-edited cell therapy, for global commercial supply…
Gold Royalty Announces Agreement to Acquire Vares Copper Stream
Gold Royalty Corp. (“Gold Royalty” or the “Company”) (NYSE American: GROY) - https://www.commodity-tv.com/... - is plea…
Lonza Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from Roche
Lonza has signed an agreement to acquire the Genentech manufacturing facility in Vacaville (US) from Roche for USD 1.2 b…
Lonza Announces New Filling Line for Commercial Supply of Antibody-Drug Conjugates for a Dedicated Customer
The new cGMP filling line at Lonza’s Stein (CH) site will enable handling and filling of bioconjugates for commercia…
Dymax 9771 Conformal Coating Receives MIL-I-46058C Certification for Printed Circuit Board Assemblies
Dymax, a leading manufacturer of light-curing materials and equipment, is pleased to announce that their ground-breaking…
Dymax 9771 Conformal Coating für die Montage von Leiterplatten jetzt mit MIL-I-46058C-Zertifizierung
Dymax, einer der international führenden Hersteller von lichthärtenden Materialien und Geräten, freut sich bekannt zu ge…
Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
Lonza to acquire Synaffix B.V., an innovative biotech company focused on antibody-drug conjugates (ADCs) Acquisition w…